Coverage
-
November 13, 2026
A health advocacy group and three dietary supplement sellers urged a D.C. federal judge Friday to rule the U.S. Food and Drug Administration overstepped when it rejected over a hundred label claims for supplement products that connected certain nutrients to health outcomes.
1 other articles on this case.
View all »